홈
탐색
nav.journalClub
트렌드
더보기
synapse
⌘+K
언어
한국어
한국어
March 3, 2026
Asiatic acid promotes CD8+ T cell-mediated antitumor immunity by targeting HDAC8/CXCL10 axis in hepatocellular carcinoma
WM
Weifang Ma
Chinese Academy of Medical Sciences & Peking Union Medical College
XG
Xuelian Gao
Guangdong Provincial Center for Disease Control and Prevention
GZ
Ge Zeng
Nanfang Hospital
See all
Key Points
Asiatic acid promotes enhanced CD8+ T cell-mediated antitumor immunity.
The investigation highlights a significant increase in CXCL10 levels after treatment with asiatic acid.
Assessment using a target approach revealed the involvement of the HDAC8 pathway.
The findings support further exploration of asiatic acid as a therapeutic option for hepatocellular carcinoma.
Mark Helpful
Like
Save
Bookmark
Relay
Share
Mark Helpful
Like
Save
Bookmark
Relay
Share
Cite This Study
Copy
Liu et al. (Thu,) studied this question.
synapsesocial.com/papers/69a767ebbadf0bb9e87e2e34
https://doi.org/https://doi.org/10.1038/s41401-025-01739-9
아시안산은 간세포암에서 HDAC8/CXCL10 축을 표적으로 하여 CD8+ T 세포 매개 항종양 면역을 촉진합니다. | Synapse